![Harish Shantharam](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Harish Shantharam
Finanzdirektor/CFO bei
ALX ONCOLOGY HOLDINGS INC.
Vermögen: 151 320 $ am 31.07.2026
Profil
Harish Shantharam currently works at ALX Oncology Holdings, Inc., as Chief Financial Officer from 2025.
Mr. Shantharam also formerly worked at CymaBay Therapeutics, Inc., as Chief Financial & Accounting Officer in 2024, Gilead Sciences, Inc., as Vice President-Global Commercial Finance from 2011 to 2022, and Amgen, Inc., as Head-Business Development from 2004 to 2011.
Mr. Shantharam received his graduate degree from The University of Texas at Arlington and Masters Business Admin degree from UCLA Anderson School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 78.000 ( 0,06 % ) | 151 320 $ | 31.07.2026 |
Aktive Positionen von Harish Shantharam
| Unternehmen | Position | Beginn |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Finanzdirektor/CFO | 21.01.2025 |
Ehemalige bekannte Positionen von Harish Shantharam
| Unternehmen | Position | Ende |
|---|---|---|
| CYMABAY THERAPEUTICS, INC. | Finanzdirektor/CFO | 22.03.2024 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.05.2022 |
| AMGEN INC. | Corporate Officer/Principal | 01.11.2011 |
Ausbildung von Harish Shantharam
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
86
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
The University of Texas at Arlington
 The University of Texas at Arlington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ALX Oncology Holdings, Inc.
 ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer | Health Technology |
